Show the Working

End Gender Price Gap and Period Poverty

Liberal Democrat · what the evidence says

An independent, source-checked look at Liberal Democrat’s policy “End Gender Price Gap and Period Poverty” — what it would actually do across the things that affect your life. Every claim below quotes the source behind it. How this works.

Cost of living — Helps

moderate · moderate confidence

This policy would cut costs for women by banning higher prices on identical products and making period products free — both directly reducing what lower-income women spend on essentials. The main uncertainty is whether a gender-pricing ban can be enforced effectively in practice.

The evidence

Biggest unknown: Whether legislation banning gender-based price disparities can be practically enforced across retail markets, and how widely free period products would be accessed given ongoing stigma barriers.

Our reading: The evidence base here is reasonably consistent across the two strands of the policy. On gender pricing: multiple sources converge on women paying 37–40% more for comparable products, while simultaneously earning less — 12.8% less by median hourly pay for all employees. This double squeeze means the pricing ban, if enforceable, would directly lift real disposable income for women, particularly lower-income households who spend the highest proportion of income on essentials (64% vs 53% for men). The magnitude is moderate rather than major because the total annual saving per household is meaningful but not transformative, and enforcement of a pricing ban across retail markets is genuinely uncertain — the evidence does not quantify what share of the gap would be closed. On period poverty: the scale of the problem is well-evidenced (up to 1 in 5 in 2023; £500 annual spend; millions forced to trade off period products against food and energy). A legal right to free products directly removes a real cost-of-living pressure for the most affected. Scotland's prior implementation provides a real-world precedent, though uptake issues due to stigma limit the reach of the benefit in practice. The combined effect on O2 is an improvement — lower prices on gendered goods and eliminated period product costs both reduce what women must spend on essentials. The improvement is concentrated on lower-income women and those in period poverty, where the real-terms effect on disposable income is most meaningful. Confidence is moderate because the gender-pricing enforcement mechanism is unspecified and delivery challenges are real, but the direction of effect is clearly positive.

Equal treatment & democratic rights — Helps

moderate · moderate confidence

This policy tackles two documented forms of gender-based unequal treatment: women paying more for identical products, and menstruating people being unable to afford basic necessities. Both address genuine equality gaps, and Scotland's law shows the period-products element is deliverable — though the pink-tax ban would need new legislation with no clear UK precedent.

The evidence

Biggest unknown: Whether a gender pricing prohibition can be effectively defined and enforced in UK law — the 2016 attempt did not advance, and distinguishing 'practically identical' products in court is legally complex.

Our reading: O9 covers equal treatment and anti-discrimination, and both elements of this policy directly target documented gender-based inequalities. The gender price gap — women paying ~37% more for comparable products (E2) — is a form of market-based unequal treatment by sex. Prohibiting it would strengthen equal-treatment norms in commerce. However, no equivalent UK legislation exists (E10), a previous attempt stalled (E11), and defining 'practically identical' products raises real enforcement challenges. This element improves the direction for O9 but with implementation uncertainty. The period-products right directly addresses unequal access to a basic health necessity on grounds of sex. With 2.8 million people affected (E16) and evidence that period poverty forces missed school and work (E20), the access gap is real and material. Scotland's Act (E30) shows this is a deliverable statutory instrument, not mere aspiration — the committed mechanism ('a right') is legally concrete. The main caveat is that stigma persists even where rights exist (E33, E24), limiting real-world uptake without accompanying cultural change. Together, the two measures represent a substantive advance in equal treatment — one through non-discrimination law, one through a new access right. The period-products element is the stronger of the two on O9 given Scotland's precedent; the pink-tax ban is directionally sound but legally untested in UK context. Overall direction is 'improves' at moderate magnitude, since both mechanisms are real, the affected population is large, and at least one element has a proven model.